Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Windtree Therapeutics Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 27 | 27 | 0 |
| Shares | 1.73M | 1.64M | −92.3K (−5.3%) |
| Value | $518.7K | $276.6K | −$242.1K (−46.7%) |
New holders (3)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 32,999 | $5.00K | 0.00% |
| Warberg Asset Management LLC | 25,000 | $4.26K | 0.00% |
| Cetera Advisors LLC | 10,299 | $1.75K | 0.00% |
Sold out (3)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 20,148 | $6.00K |
| Susquehanna International Group, LLP | 16,075 | $5.00K |
| Addison Advisors LLC | 166 | $0 |